(2R,6S)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid(CAS: 98665-20-4)

The compound has a crystalline form and a molecular weight of approximately 856.9 g/mol. It is slightly soluble in water and organic solvents. Chemically, it is stable under normal conditions but can react with strong bases. It is not flammable and has a pKa of about 3.2.

This compound is typically synthesized via a multi-step process involving the condensation of a cyclopentaphenanthrene derivative with a 6-hydroxy-2-methyl-4-oxoheptanoic acid. The reaction is catalyzed by a palladium complex, achieving a high yield and selectivity.

This compound is primarily used in the pharmaceutical industry for its potential as an anti-inflammatory and anti-tumor agent. It may also have applications in polymer science for developing new materials with specific properties.

Proper personal protective equipment (PPE) including gloves, goggles, and a lab coat should be worn. The compound should be handled in a well-ventilated area or a fume hood. In case of a spill, it should be cleaned up using appropriate absorbent materials. For detailed safety information, refer to the Safety Data Sheet (SDS) and follow all local regulations.